Relay Therapeutics reports phase 3 trial data for breast cancer drug

March 16, 2026 7:00 AM

Relay Therapeutics Inc. (NASDAQ: RLAY) presented data from its Phase 1/2 ReDiscover trial of zovegalisib combined with fulvestrant at the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found